Ledger.Open graph →
SEC Form D · Amendment · filed December 2, 2016

BIOSORTIA PHARMACEUTICALS, INC

Offering
$3.5M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Robert O. Kamerschen · New Canaan, CTDirectorRon O. Moss · Dublin, OHDirectorRoss O. Youngs · Dublin, OHExec · DirectorDouglas L. Poling · Fairfield, CTDirectorHenry O. Cialone · Columbus, OHDirectorDerrell L. Porter · Dublin, OHDirectorAlan H. Tooker · Grand Cayman, Cayman IslandsDirectorBenjamin Mayer · MIAMI, FLExec · DirectorCraig Cartner · Sydney, Channel IslandsDirectorRebecca Ginzburg · New York, NYDirectorGustavo Alfonso · MIAMI, FLDirectorNayan Pathak · MIAMI, FLDirectorSanto J. Costa · Durham, NCDirectorP. G. Deese · Atlanta, GAExec · DirectorJoseph L. Mathias, Iv · Atlanta, GADirectorJohn-Mark Considine · Breganzona, V8DirectorSusan B. Butler · Tucson, AZDirectorCharles J. Provance · Bowling Green, KYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗